Becker's Healthcare June 14, 2024
Around 1 in 3 employers covered GLP-1 drugs for weight loss in 2023, a survey from the International Foundation of Employee Benefit Plans found.
In 2023, 34% of employers surveyed covered GLP-1 drugs for weight loss, and 57% covered the drugs to treat Type 2 diabetes. The number of employers covering the cost of the drugs for weight loss increased from 28% in 2022.
The nonprofit educational platform’s survey, published June 13, polled 279 large employers.
The average cost of GLP-1 drugs as a share of employers’ total healthcare costs rose to 8.9% in 2023, up from 6.9% in 2022. The majority of employers surveyed, 85%, reported relying on utilization management to control costs. Most employers covering...
Today's Sponsors
Today's Sponsor